This conference will provide crucial guidance and relevant updates on all of the key issues affecting pharmaceutical lifecycles in Europe and internationally.

As the area of pharmaceutical patent lifecycles becomes increasingly complex, with pharmaceutical products fast approaching a “patent cliff,” it is estimated that in 2015 $47.5 billion of lost sales affected the industry overall. It is critical for pharmaceutical companies to capitalise on their R&D expenditure by obtaining Supplementary Protection Certificates in Europe, but there are also other legal and technical ways to extend patent terms in Europe and around the world.

This conference will explore a range of topical issues to ensure you are in the best possible position to extend your patent lifecycles. Sessions covered will include the evolving landscape of SPC regulation, the impact of the latest case law application on SPCs, and the extent of patent protection for Pharmaceutical inventions. It will also provide you with the implementable tools to extend your patents’ lifecycle in those countries which do not offer patent term extensions, offering you exclusive updates in critical markets, as well as digging deeper into the impact of TPP on patent term extensions.

Delivered by established and highly reputable experts from the pharmaceutical and legal industry, this is a must attend Forum for in-house and private practice patent attorneys and lawyers to gather and share the latest information on SPCs’ case law and best practices and strategies to extend the protection given by their patents.

Participants will receive a comprehensive set of valuable materials prepared by the speakers specifically for this event. These are materials that you will be able to use again and again.